
Helen K. Chew
Hematology & Oncology · Regents of the Univ of Ca
Credentials: ·
History
- 1996–2000
University of Texas Health Sciences Center
- 1995–1998
University of Texas Health Sciences Center
- 1991–1994
University of Texas Health Sciences Center
- 1991
University of Texas Health Sciences Center
Research
Incidence of venous thromboembolism and its effect on survival among patients with common cancers
Archives of Internal Medicine · 2006 · First of 5 authors · Corresponding · 1,015 citations
Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2022 · 759 citations
Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2024 · 560 citations

9 papers

7 papers

6 papers · 1 as a fellow

Gabriel Hortobagyi
6 papers

6 papers

6 papers
- JG
6 papers

6 papers
Grants
- 2002–2031
Cancer Center Support Grant P30
National Cancer Institute · P30
Project lead · $820.5K · University of California at Davis
- 2002–2005
Venous Thromboembolism Among California Cancer Patients
National Cancer Institute · R03
Contact PI · $148.5K · University of California at Davis
- 2004–2005
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $4.9K · University of California at Davis
Clinical trials
- 2009–2011
Lapatinib and Ixabepilone in Treating Patients With Advanced Solid Tumors
Principal investigator · Terminated · Phase 1
University of California, Davis
- 2003–2010
GTI-2040 and Capecitabine in Treating Patients With Metastatic Breast Cancer
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)
- 2006–2016
Blood Glycan Biomarkers in Women With Stage IV Breast Cancer
Study chair · Completed
University of California, Davis
- 2005–2011
Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors
Study chair · Completed · Phase 1
University of California, Davis


